Lemos et al. found that c-Myc-mediated glycolysis plays a central role in energy metabolism in patients with chronic renal failure, which confirms the key role of the IL-1β/c-Myc pathway in this process and clarifies the relationship between inflammation, glycolysis, and RIF [11]. Here, MYC is linked to chronic kidney disease.